The Center for Sickle Cell Disease has received a $7 million program award, the second phase of a Research Centers Program at minority institutions, from the National Heart, Lung and Blood Institute (NHLBI). The research program will provide the necessary means to train and engage minority populations in biomedical and translational research. Howard University proposed the creation of the Center for Hemoglobin Research in Minorities (CHaRM), which will build on the existing HBCU Research Scientist Program established at the Center for Sickle Cell Disease. CHaRM will be led by Robert E. Taylor, MD, PhD, Professor of Pharmacology & Medicine, Chair of the Department of Pharmacology and HUCM Dean Emeritus.